Come up with a name for your new list and we'll add to it:
Integral Molecular raised a round of funding on December 18, 2013. Investors include
U.S. Department of Health and Human Services.
Integral Molecular develops technologies to enable the discovery and development of drugs that target integral membrane proteins, which are involved directly or indirectly in most major diseases, and …